Subscribe To Our Free Newsletter |
Buy Marksans Pharma; target of Rs 80: Arihant Capital
Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 80 in its research report dated August 19, 2022.